The emerging role of long non-coding RNAs in cutaneous melanoma

Eleonora Leucci, Elizabeth A. Coe, Jean-Christophe Marine, Keith W. Vance

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Malignant melanoma is a highly aggressive form of skin cancer, the incidence of which is rising rapidly. Although MAPK-targeting therapies and immune checkpoint blockade are emerging as attractive therapeutic approaches, their utility is limited to only a subset of patients who often acquire resistance. A better understanding of the aetiologies and genetic underpinnings of melanoma is therefore critical for the development of adjuvant or alternative therapeutic strategies aimed at increasing the proportion of responders and improving treatment efficacy. A key step in identifying novel therapeutic targets may be the shift in focus from the protein-coding components to the non-coding portion of the genome. The latter, representing about 98% of the genome, serves as a template for the transcription of many thousands of long non-coding RNAs (lncRNAs). Intriguingly, lncRNA loci are frequently mutated or altered in a variety of cancers, including melanoma, and there is growing evidence that lncRNAs can function as cancer-causing oncogenes or tumour suppressors. In this review, we summarize recent data highlighting the importance of lncRNAs in the biology of melanoma and their potential utility as biomarkers and therapeutic targets.

Original languageEnglish
Pages (from-to)619-626
JournalPigment Cell & Melanoma Research
Volume29
Issue number6
Early online date8 Sep 2016
DOIs
Publication statusPublished - 1 Nov 2016

Fingerprint

Long Noncoding RNA
Melanoma
Skin
Genes
Genome
Biomarkers
Transcription
Therapeutics
Neoplasms
Tumors
Skin Neoplasms
Oncogenes
Incidence
Proteins

Cite this

The emerging role of long non-coding RNAs in cutaneous melanoma. / Leucci, Eleonora; Coe, Elizabeth A.; Marine, Jean-Christophe; Vance, Keith W.

In: Pigment Cell & Melanoma Research, Vol. 29, No. 6, 01.11.2016, p. 619-626.

Research output: Contribution to journalArticle

@article{9894a0f126af4b3581eaa0e73c1694ee,
title = "The emerging role of long non-coding RNAs in cutaneous melanoma",
abstract = "Malignant melanoma is a highly aggressive form of skin cancer, the incidence of which is rising rapidly. Although MAPK-targeting therapies and immune checkpoint blockade are emerging as attractive therapeutic approaches, their utility is limited to only a subset of patients who often acquire resistance. A better understanding of the aetiologies and genetic underpinnings of melanoma is therefore critical for the development of adjuvant or alternative therapeutic strategies aimed at increasing the proportion of responders and improving treatment efficacy. A key step in identifying novel therapeutic targets may be the shift in focus from the protein-coding components to the non-coding portion of the genome. The latter, representing about 98{\%} of the genome, serves as a template for the transcription of many thousands of long non-coding RNAs (lncRNAs). Intriguingly, lncRNA loci are frequently mutated or altered in a variety of cancers, including melanoma, and there is growing evidence that lncRNAs can function as cancer-causing oncogenes or tumour suppressors. In this review, we summarize recent data highlighting the importance of lncRNAs in the biology of melanoma and their potential utility as biomarkers and therapeutic targets.",
author = "Eleonora Leucci and Coe, {Elizabeth A.} and Jean-Christophe Marine and Vance, {Keith W.}",
note = "This article is protected by copyright. All rights reserved.",
year = "2016",
month = "11",
day = "1",
doi = "10.1111/pcmr.12537",
language = "English",
volume = "29",
pages = "619--626",
journal = "Pigment Cell & Melanoma Research",
issn = "1755-1471",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - The emerging role of long non-coding RNAs in cutaneous melanoma

AU - Leucci, Eleonora

AU - Coe, Elizabeth A.

AU - Marine, Jean-Christophe

AU - Vance, Keith W.

N1 - This article is protected by copyright. All rights reserved.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Malignant melanoma is a highly aggressive form of skin cancer, the incidence of which is rising rapidly. Although MAPK-targeting therapies and immune checkpoint blockade are emerging as attractive therapeutic approaches, their utility is limited to only a subset of patients who often acquire resistance. A better understanding of the aetiologies and genetic underpinnings of melanoma is therefore critical for the development of adjuvant or alternative therapeutic strategies aimed at increasing the proportion of responders and improving treatment efficacy. A key step in identifying novel therapeutic targets may be the shift in focus from the protein-coding components to the non-coding portion of the genome. The latter, representing about 98% of the genome, serves as a template for the transcription of many thousands of long non-coding RNAs (lncRNAs). Intriguingly, lncRNA loci are frequently mutated or altered in a variety of cancers, including melanoma, and there is growing evidence that lncRNAs can function as cancer-causing oncogenes or tumour suppressors. In this review, we summarize recent data highlighting the importance of lncRNAs in the biology of melanoma and their potential utility as biomarkers and therapeutic targets.

AB - Malignant melanoma is a highly aggressive form of skin cancer, the incidence of which is rising rapidly. Although MAPK-targeting therapies and immune checkpoint blockade are emerging as attractive therapeutic approaches, their utility is limited to only a subset of patients who often acquire resistance. A better understanding of the aetiologies and genetic underpinnings of melanoma is therefore critical for the development of adjuvant or alternative therapeutic strategies aimed at increasing the proportion of responders and improving treatment efficacy. A key step in identifying novel therapeutic targets may be the shift in focus from the protein-coding components to the non-coding portion of the genome. The latter, representing about 98% of the genome, serves as a template for the transcription of many thousands of long non-coding RNAs (lncRNAs). Intriguingly, lncRNA loci are frequently mutated or altered in a variety of cancers, including melanoma, and there is growing evidence that lncRNAs can function as cancer-causing oncogenes or tumour suppressors. In this review, we summarize recent data highlighting the importance of lncRNAs in the biology of melanoma and their potential utility as biomarkers and therapeutic targets.

UR - http://dx.doi.org/10.1111/pcmr.12537

U2 - 10.1111/pcmr.12537

DO - 10.1111/pcmr.12537

M3 - Article

VL - 29

SP - 619

EP - 626

JO - Pigment Cell & Melanoma Research

JF - Pigment Cell & Melanoma Research

SN - 1755-1471

IS - 6

ER -